fundvisualizer.com

T. Rowe Price QM US Value Equity AdvTQVAX

Performance (before sales charge)

As of 02/28/2023

All information is historical and not indicative of future results. Current performance may be lower or higher than the quoted past performance, which cannot guarantee results. Share price, principal value, and return will vary, and you may have a gain or a loss when you sell your shares. Performance assumes reinvestment of distributions and does not account for taxes. After-sales-charge returns reflect the maximum sales charge applicable to the fund. Performance may not reflect any expense limitation or subsidies currently in effect. Short-term trading fees may apply. To obtain the most recent month-end performance, visit Morningstar.com.

Asset allocation

As of 12/31/2022
Stock
95.28%
Non-U.S. Stock
3.62%
Bond
0.00%
Non-U.S. Bond
0.00%
Preferred
0.00%
Convertible
0.00%
Cash
1.10%
Other
0.00%

Due to rounding, percentages may not equal 100%.

Sectors

As of 12/31/2022

Basic materials

2.55%

Consumer cyclical

8.30%

Financial services

19.52%

Real estate

3.02%

Consumer defensive

7.12%

Health care

18.29%

Utilities

4.19%

Communication services

5.46%

Energy

8.62%

Industrials

11.34%

Technology

10.46%

Top 10 holdings

As of 12/31/2022

Exxon Mobil Corp
2.77%
T. Rowe Price Gov. Reserve
2.68%
JPMorgan Chase & Co
2.46%
Chevron Corp
2.21%
Bank of America Corp
1.89%
Johnson & Johnson
1.84%
Pfizer Inc
1.80%
Philip Morris International Inc
1.66%
Wells Fargo & Co
1.64%
Cash & Cash Equivalents
1.58%
Fund assets

$35 Million

Share class

Adv

Morningstar category

Large Value

Expense ratio

0.99%

Investment objective

Growth

Documents